Fusion IP completes £1.25m Asalus funding round

News

Fusion IP, the university IP commercialisation company, has announced that Asalus Medical Instruments has completed a £1.25m funding round.

The funds will be used to complete the manufacture and CE marking of its Ultravision technology prior to its planned launch in the second half of 2013.

Ultravision — a smoke clearance device in which electrosurgical smoke is cleared from minimal access and open surgical procedures — is one product in a range of laparoscopic surgery devices being developed by Asalus.

Asalus’s two other products are Surehold, a multi-functional device for the atraumatic manipulation of tissues and organs; and Snugport, a laparoscopic access port that is claimed to provide significant benefits over those currently on the market.

The £1.25m funding includes investments from existing investors Fusion, Finance Wales and IP Group.

As a result of the funding, Fusion will own a 44 per cent undiluted shareholding in Asalus.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox

Register
Or continue by

Signing in with your registered email address